• Four men with amyotrophic lateral sclerosis (ALS) were treated with 200 mg of intramuscular testosterone weekly. Endocrine evaluation, using a gonadotropin-releasing hormone infusion test, indicated the expected degree of suppression of pituitary luteinizing hormone and follicle-stimulating hormone production. These data suggest that testosterone's (androgen) interaction with its receptors in the hypothalamic-pituitary axis is normal in patients with ALS.
Jones TM, Yu R, Antel JP. Response of Patients With Amyotrophic Lateral Sclerosis to Testosterone Therapy: Endocrine Evaluation. Arch Neurol. 1982;39(11):721–722. doi:10.1001/archneur.1982.00510230047014
Monkeypox Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.